Cell Therapeutics (CTIC +0.9%) gains after the company receives a Notice of Allowance from the...

|About: CTI BioPharma Corp. (CTIC)|By:, SA News Editor

Cell Therapeutics (CTIC +0.9%) gains after the company receives a Notice of Allowance from the U.S. Patent and Trademark Office for an application directed to increasing the plasma half-life of therapeutic proteins and peptides by recombinantly conjugating them to a unique, non-immunogenic peptide repeat sequence.